In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation by C. Lange, N. Lindo, R. Little, T. Uldrick, S. Hill, J. Bell, K. Lurain, R. Ramaswami, R. Yarchoan, F. Maldarelli

Get full text

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues by F. Maldarelli, M. Gozoulis, X. Wu, L. Perez, R. Gorelick, C. Lange, S. Hill, J. Virga, T. Uldrick, R. Yarchoan, S. Hughes

Get full text

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy by G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli

Get full text

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo by S.A. Watters, M.N. Polizzotto, W. Shao, R. Gorelick, E.M. Anderson, I. Sereti, K. Aleman, L. Kouyoudjian, J.B. Zeldis, T. Uldrick, R. Yarchoan, F. Maldarelli

Get full text

Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer by T.S. Uldrick, M.A. ‘Mac’ Cheever, P.H. Gonçalves, S. Fling, K. Aleman, B. Emu, M.S. Ernstoff, R. Gorelick, J. Kaiser, H. E Kohrt, A. Lacroix, M. Lindsley, L. M Lundgren, K. Lurain, F. Maldarelli, C. Parsons, E. Sharon, A. Widell, R. Yarchoan

Get full text